Joel Shacker

Core One Labs Inc. (OTCQB: CLABF) (CSE:COOL)(Frankfurt:LD6), (WKN:A3CSSU) announced that it is in discussions with several pharmaceutical laboratories and research organizations to supply them with active pharmaceutical ingredient psilocybin to meet their psychedelic research needs. Scientific...

Core One Labs Inc. (OTCQB: CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN:A3CSSU) announced that its wholly-owned subsidiary, Awakened Biosciences Inc. has successfully completed the first synthetic production of psilocin at the GMP manufacturing facility of its recently acquired GMP Drug Inc. "...

With psilocybin among the favorites within psychedelics, Core One Labs Inc. (OTCQB: CLABF) is joining Optimi Health (OTC PINK: OPTHF) to formally begin sales for its own biosynthetic API psilocybin product. On August 26, the company began discussions with a development and...

Psychedelics company Core One Labs Inc. (CSE: COOL) (OTCPINK: CLABF) is expanding into the functional mushroom space with the acquisition of New Path Laboratories Inc., a British Columbia-based company dedicated to the development and licensing of natural health products and dietary supplements....